NUVB Q1 2025 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$990,00032.1% margin

Operating Income

-$59M-1913.2% margin

Net Income

-$53M-1726.2% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-46.0%

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$492M

Total Liabilities

$73M

Stockholders' Equity

$419M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$990,000	$0	—
Operating Income	-$59M	-$20M	-192.1%
Net Income	-$53M	-$15M	-259.9%

Revenue Segments

Product Revenue

$779,00076%

Royalty Revenue

$249,00024%

Geographic Segments

CHINA

$3M94%

JAPAN

$200,0006%